Loading...
Fenofibrate — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Fenofibrate
2025-Q4
Comprehensive analysis of India’s fenofibrate export trade — suppliers, buyers, prices, routes, and every shipment record.
241
Shipments
$6.33M
Trade Value
46
Suppliers
51
Buyers
40
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/fenofibrate
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s fenofibrate trade — 2025-Q4
KEY TAKEAWAY
Fenofibrate 2025-Q4 exports total $6.3M across 40 countries, with ABBOTT HEALTHCARE PVT LTD commanding 32.2% market share.
TOTAL SHIPMENTS
241
2025-Q4
EXPORT VALUE
$6.3M
FOB USD
TOTAL QUANTITY
64.2M
units shipped
INDIAN SUPPLIERS
46
unique exporters
GLOBAL BUYERS
51
unique importers
DESTINATIONS
40
countries
MEDIAN UNIT PRICE
$0.715
per unit
TOP-5 SHARE
76.4%
of total USD
BRANDED SHARE
52.7%
127 shipments
DOSAGE FORMS
5
product types
6 KEY FINDINGS
1
ABBOTT HEALTHCARE PVT LTD is India's #1 Fenofibrate exporter with $2.0M (32.2% market share).→ §5, Indian Supplier Rankings
2
Fenofibrate reached 40 countries, with United States as the top destination ($2.2M).→ §4, Global Destination Map
3
Market concentration is moderate (HHI: 1645) — top 10 suppliers control 92.0% of exports.→ §5, Indian Supplier Rankings
4
94.1% of buyers (48 of 51) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (76.5%) across 5 dosage forms.→ §7, Price Benchmarks
6
39 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 ABBOTT HEALTHCARE PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian fenofibrate exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Fenofibrate report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial fenofibrate trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian fenofibrate suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Fenofibrate India trade report
Product scope
Fenofibrate
All variants merged — branded and generic formulations of fenofibrate
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
241
Every commercial fenofibrate trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a steady rise: Oct $1.7M, Nov $2.1M, Dec $2.5M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.7M
Oct USD
65 shipments
2
$2.1M
Nov USD
+28.7% MoM
3
$2.5M
Dec USD
+18.5% MoM
4
Steady rise
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 28.7% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.7M, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $6.3M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $477K rise in Nov, $395K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1.7M | 65 shipments |
| Nov | $2.1M | 97 shipments |
| Dec | $2.5M | 79 shipments |
| Q4 Total | $6.3M | 241 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Hungary held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: ABBOTT HEALTHCARE PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import fenofibrate from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 34.1% of India’s 2025-Q4 fenofibrate trade ($2.2M). Beyond the top 10 destinations, 39 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 12 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 39 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much fenofibrate India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$797K
12.6% of trade
12 countries · 59 shipments
Europe
$2.5M
39.3% of trade
9 countries · 35 shipments
Americas
$2.4M
38.1% of trade
8 countries · 116 shipments
Africa
$21K
0.3% of trade
9 countries · 20 shipments
Oceania
$608K
9.6% of trade
2 countries · 11 shipments
Fig 4.1 United States is the #1 corridor ($2.2M) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian fenofibrate it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $2.2M | 98 | CIPLA LTD | $563K | HETERO LABS LTD | $497K | AMNEAL PHARMACEUTICALS PVT LTD | $329K |
| 2 | Hungary | $1.3M | 6 | ABBOTT HEALTHCARE PVT LTD | $1.3M | — | — | — | — |
| 3 | Slovenia | $719K | 3 | ABBOTT HEALTHCARE PVT LTD | $719K | — | — | — | — |
| 4 | Australia | $607K | 10 | CIPLA LTD | $339K | HETERO LABS LTD | $269K | — | — |
| 5 | South Korea | $548K | 1 | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | $548K | — | — | — | — |
| 6 | Brazil | $151K | 3 | COHANCE LIFESCIENCES LTD | $137K | TORRENT PHARMACEUTICALS LTD | $14K | — | — |
| 7 | Belgium | $125K | 5 | SUN PHARMACEUTICAL INDUSTRIES LTD | $125K | — | — | — | — |
| 8 | Germany | $117K | 8 | TORRENT PHARMACEUTICALS LTD | $117K | — | — | — | — |
| 9 | United Kingdom | $95K | 4 | TORRENT PHARMACEUTICALS LTD | $95K | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | $405 | — | — |
| 10 | Malta | $75K | 5 | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | $44K | TORRENT PHARMACEUTICALS LTD | $31K | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 12.6% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
34.1%
#1 country share
United States alone
84.5%
Top 5 share
5 of 40 countries
97.5%
Top 15 share
Long tail of 25 countries = 2.5%
HHI 1911
Destination HHI
Moderately concentrated
40
Countries served
Global pharma reach from India
12
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
46 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
ABBOTT HEALTHCARE PVT LTD ($2.0M, 32.2% share) and CIPLA LTD ($976.7K) together control 47.6% of India’s 2025-Q4 fenofibrate trade. The top 5 suppliers hold 76.4%. 46 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian fenofibrate suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ABBOTT HEALTHCARE PVT LTD leads by $1.1M over CIPLA LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: COHANCE LIFESCIENCES LTD is #10 by value but #17 by volume.
Fig 5.2 CIPLA LTD also leads by shipment count (36) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: COHANCE LIFESCIENCES LTD moves from #17 by volume to #10 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 46 fenofibrate suppliers split into strategic segments
KEY TAKEAWAY
12 suppliers (25%) generate 95.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ABBOTT HEALTHCARE PVT LTD and CIPLA LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 95.6% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | 3 | 5 | $633K |
| 2 | CIPLA LTD | 2 | 3 | $977K |
| 3 | TORRENT PHARMACEUTICALS LTD | 2 | 4 | $257K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LTD | 2 | 1 | $125K |
| 5 | ABBOTT HEALTHCARE PVT LTD | 1 | 3 | $2.0M |
| 6 | HETERO LABS LTD | 1 | 4 | $859K |
| 7 | AMNEAL PHARMACEUTICALS PVT LTD | 1 | 1 | $329K |
| 8 | MANKIND PHARMA LTD | 1 | 1 | $226K |
| 9 | ALEMBIC PHARMACEUTICALS LTD | 1 | 2 | $220K |
| 10 | INVENTIA HEALTHCARE LTD | 1 | 1 | $150K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the fenofibrate manufacturing hubs
KEY TAKEAWAY
Solan and Hyderabad together account for $3.0M of India’s 2025-Q4 fenofibrate trade.
Fig 5.5 Solan (1 exporters, $2.0M) and Hyderabad (2 exporters, $996K) are India’s fenofibrate capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
76.4%
Top 5 share
5 of 46 suppliers
92.0%
Top 10 share
10 of 46 suppliers
95.6%
Top 25% share
12 suppliers = 96% USD
HHI 1645
Supplier HHI
Moderate
46
Total suppliers
shipped Fenofibrate in 2025-Q4
20+ cities
Indian hubs
Solan and Hyderabad lead
§5.2 Coming next: 6 exporter deep-dive profiles
Each of the top 6 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | ABBOTT HEALTHCARE PVT LTD | $2.0M |
| #2 | CIPLA LTD | $977K |
| #3 | HETERO LABS LTD | $859K |
| #4 | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | $633K |
| #5 | TORRENT PHARMACEUTICALS LTD | $257K |
| #6 | ALEMBIC PHARMACEUTICALS LTD | $220K |
#1
EXPORTER PROFILE #1 OF 6
ABBOTT HEALTHCARE PVT LTD
Solan · India’s #1 fenofibrate supplier by USD · 2025-Q4
2025-Q4 USD
$2.0M
32.2% market share
SHIPMENTS
11
avg $185K/ship
COUNTRIES
3
destination markets
BUYERS
3
2 single-sourced
BRANDED
18%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
Hungary is the #1 market at $1.3M (65% of trade), followed by Slovenia at $719K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Hungary | $1.3M | 6 | 64.6% |
| 2 | Slovenia | $719K | 3 | 35.3% |
| 3 | France | $868 | 2 | 0.0% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $1.2M.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MYLAN HUNGARY KFT | Hungary | $2.0M | ⚠ Locked |
| ASTREA FONTAINE SAS | France | $434 | ⚠ Locked |
| Undisclosed buyer | France | $434 | N/A |
#1
EXPORTER PROFILE #1 OF 6 — TRADE FLOW MAP
ABBOTT HEALTHCARE PVT LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P1.3 Hungary absorbs $1.3M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
#2
EXPORTER PROFILE #2 OF 6
CIPLA LTD
Parel Mumbai Maharashtra · India’s #2 fenofibrate supplier by USD · 2025-Q4
2025-Q4 USD
$977K
15.4% market share
SHIPMENTS
36
avg $27K/ship
COUNTRIES
3
destination markets
BUYERS
4
3 single-sourced
BRANDED
69%
of shipments
DOSAGE FORMS
2
product types
TOP 3 DESTINATIONS
United States is the #1 market at $563K (58% of trade), followed by Australia at $339K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $563K | 28 | 57.7% |
| 2 | Australia | $339K | 6 | 34.7% |
| 3 | Panama | $75K | 2 | 7.6% |
MONTHLY TREND
Nov peaked at $562K. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 92% of trade. Capsule (7.6%) and others are secondary formulations.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| CIPLA USA INC | United States | $359K | ⚠ Locked |
| ARROW PHARMACEUTICALS … | Australia | $339K | ⚠ Locked |
| Undisclosed buyer | United States | $205K | N/A |
| AGENCIAS CELMAR | Panama | $75K | ⚠ Locked |
#2
EXPORTER PROFILE #2 OF 6 — TRADE FLOW MAP
CIPLA LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P2.3 United States absorbs $563K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
#3
EXPORTER PROFILE #3 OF 6
HETERO LABS LTD
Hyderabad · India’s #3 fenofibrate supplier by USD · 2025-Q4
2025-Q4 USD
$859K
13.6% market share
SHIPMENTS
29
avg $30K/ship
COUNTRIES
4
destination markets
BUYERS
4
3 single-sourced
BRANDED
7%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
United States is the #1 market at $497K (58% of trade), followed by Australia at $269K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $497K | 21 | 57.8% |
| 2 | Australia | $269K | 4 | 31.3% |
| 3 | Saudi Arabia | $68K | 3 | 7.9% |
| 4 | Oman | $26K | 1 | 3.0% |
MONTHLY TREND
Oct peaked at $635K. Nov was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | United States | $543K | N/A |
| SADDOZ PTY LTD | Australia | $269K | ⚠ Locked |
| OMAN PHARMACEUTICAL PR… | Oman | $26K | ⚠ Locked |
| CAMBER PHARMACEUTICALS… | United States | $21K | ⚠ Locked |
#3
EXPORTER PROFILE #3 OF 6 — TRADE FLOW MAP
HETERO LABS LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P3.3 United States absorbs $497K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#4
EXPORTER PROFILE #4 OF 6
ATHENA DRUG DELIVERY SOLUTIONS PVT LTD
Andheri East · India’s #4 fenofibrate supplier by USD · 2025-Q4
2025-Q4 USD
$633K
10.0% market share
SHIPMENTS
7
avg $90K/ship
COUNTRIES
5
destination markets
BUYERS
5
5 single-sourced
BRANDED
71%
of shipments
DOSAGE FORMS
3
product types
TOP 5 DESTINATIONS
South Korea is the #1 market at $548K (86% of trade), followed by Malta at $44K. 5 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | South Korea | $548K | 1 | 86.5% |
| 2 | Malta | $44K | 3 | 7.0% |
| 3 | Denmark | $22K | 1 | 3.5% |
| 4 | Portugal | $19K | 1 | 3.0% |
| 5 | United Kingdom | $405 | 1 | 0.1% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $548K.
PRODUCT MIX
Pellets dominates at 86% of trade. Capsule (13.5%) and Tablet are secondary formulations.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| HANLIM PHARM. CO LTD | South Korea | $548K | ⚠ Locked |
| APL SWIFT SERVICES (MA… | Malta | $44K | ⚠ Locked |
| 2CARE4 GENERICS APS | Denmark | $22K | ⚠ Locked |
| TECNIMEDE-SOCIEDADE TC… | Portugal | $19K | ⚠ Locked |
| CRESCENT PHARMA LTD | United Kingdom | $405 | ⚠ Locked |
#4
EXPORTER PROFILE #4 OF 6 — TRADE FLOW MAP
ATHENA DRUG DELIVERY SOLUTIONS PVT LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P4.3 South Korea absorbs $548K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
#6
EXPORTER PROFILE #5 OF 6
TORRENT PHARMACEUTICALS LTD
Ahmedabad. Gujarat · India’s #6 fenofibrate supplier by USD · 2025-Q4
2025-Q4 USD
$257K
4.1% market share
SHIPMENTS
15
avg $17K/ship
COUNTRIES
4
destination markets
BUYERS
5
4 single-sourced
BRANDED
80%
of shipments
DOSAGE FORMS
2
product types
TOP 4 DESTINATIONS
Germany is the #1 market at $117K (46% of trade), followed by United Kingdom at $95K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Germany | $117K | 8 | 45.6% |
| 2 | United Kingdom | $95K | 3 | 36.9% |
| 3 | Malta | $31K | 2 | 12.1% |
| 4 | Brazil | $14K | 2 | 5.4% |
MONTHLY TREND
Nov peaked at $203K. Oct was the weakest at $14K.
PRODUCT MIX
Tablet dominates at 94% of trade. film-coated tablet (6.1%) and others are secondary formulations.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| HEUMANN PHARMA GMBH | Malta | $110K | ⚠ Locked |
| TORRENT PHARMA (UK) LTD | United Kingdom | $95K | ⚠ Locked |
| Undisclosed buyer | Germany | $38K | N/A |
| TORRENT DO BRASIL LTDA… | Brazil | $14K | ⚠ Locked |
| TORRENT DO BRASIL LTDA | Brazil | $156 | ⚠ Locked |
#6
EXPORTER PROFILE #5 OF 6 — TRADE FLOW MAP
TORRENT PHARMACEUTICALS LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P5.3 Germany absorbs $117K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#8
EXPORTER PROFILE #6 OF 6
ALEMBIC PHARMACEUTICALS LTD
Gujarat · India’s #8 fenofibrate supplier by USD · 2025-Q4
2025-Q4 USD
$220K
3.5% market share
SHIPMENTS
14
avg $16K/ship
COUNTRIES
2
destination markets
BUYERS
3
2 single-sourced
BRANDED
21%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
United States is the #1 market at $216K (98% of trade), followed by Chile at $4K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $216K | 13 | 98.3% |
| 2 | Chile | $4K | 1 | 1.7% |
MONTHLY TREND
Nov peaked at $109K. Oct was the weakest at $53K.
PRODUCT MIX
Capsule dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| J. KNIPPER & COMPANY | United States | $163K | ⚠ Locked |
| Undisclosed buyer | United States | $53K | N/A |
| ALEMBIC PHARMACEUTICAL… | Chile | $4K | ⚠ Locked |
#8
EXPORTER PROFILE #6 OF 6 — TRADE FLOW MAP
ALEMBIC PHARMACEUTICALS LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P6.3 United States absorbs $216K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
51 importers across 40 countries — who is buying Indian fenofibrate and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 83.8% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian fenofibrate. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MYLAN HUNGARY KFT is the #1 importer at $2.0M (32.2%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
94%
Single-source
48 buyers rely on exactly 1 Indian supplier
2%
Dual-source
1 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
4%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source fenofibrate from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United States 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CIPLA USA INC | CIPLA LTD | $359K | $0.032 | Tablet |
| AMNEAL PHARMACEUTICALS… | AMNEAL PHARMACEUTICA… | $329K | $2.920 | Tablet |
| J. KNIPPER & COMPANY | ALEMBIC PHARMACEUTIC… | $163K | $0.018 | Capsule |
| NORTHSTAR DISTRIBUTION… | MANKIND PHARMA LTD | $117K | $1.597 | Tablet |
| LIFESTAR PHARMA LLC | MANKIND PHARMA LTD | $109K | $2.864 | Tablet |
Brazil 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| COMEXPORT TRADING COME… | COHANCE LIFESCIENCES… | $137K | $104.505 | Other |
| TORRENT DO BRASIL LTDA… | TORRENT PHARMACEUTIC… | $14K | $2.902 | Tablet |
| TORRENT DO BRASIL LTDA | TORRENT PHARMACEUTIC… | $156.248 | $0.034 | Tablet |
Philippines 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| 4LIFE HEALTHCARE INC | SASHA LIFE HEALTHCARE | $43K | $1.117 | Capsule |
| AMBICA INTERNATIONAL C… | XL LABORATORIES PVT … | $12K | $2.041 | Capsule |
| PHARMAKON BIOTEC INC | RAVIAN LIFE SCIENCE … | $38.822 | $0.013 | Tablet |
Australia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ARROW PHARMACEUTICALS … | CIPLA LTD | $339K | $0.098 | Tablet |
| SADDOZ PTY LTD | HETERO LABS LTD | $269K | $0.116 | Tablet |
Malta 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| HEUMANN PHARMA GMBH | TORRENT PHARMACEUTIC… | $110K | $0.159 | Tablet |
| APL SWIFT SERVICES (MA… | ATHENA DRUG DELIVERY… | $44K | $1.844 | Capsule |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MYLAN HUNGARY KFT | Hungary | $2.0M | $226K | Premium |
| 2 | HANLIM PHARM. CO LTD | South Korea | $548K | $548K | Premium |
| 3 | CIPLA USA INC | United States | $359K | $19K | Mid |
| 4 | ARROW PHARMACEUTICAL… | Australia | $339K | $56K | Premium |
| 5 | AMNEAL PHARMACEUTICA… | United States | $329K | $55K | Premium |
| 6 | SADDOZ PTY LTD | Australia | $269K | $67K | Premium |
| 7 | J. KNIPPER & COMPANY | United States | $163K | $15K | Budget |
| 8 | COMEXPORT TRADING CO… | Brazil | $137K | $137K | Premium |
| 9 | YUSEN LOGISTICS BENE… | Belgium | $125K | $25K | Mid |
| 10 | NORTHSTAR DISTRIBUTI… | United States | $117K | $15K | Budget |
| 11 | HEUMANN PHARMA GMBH | Malta | $110K | $14K | Budget |
| 12 | LIFESTAR PHARMA LLC | United States | $109K | $14K | Budget |
| 13 | MYLAN PHARMACEUTICAL… | United States | $105K | $52K | Premium |
| 14 | TORRENT PHARMA (UK) … | United Kingdom | $95K | $32K | Mid |
| 15 | ANIP ACQUISITION COM… | United States | $86K | $29K | Mid |
| 16 | AGENCIAS CELMAR | Panama | $75K | $37K | Premium |
| 17 | MCKESSON THIRD PARTY… | United States | $71K | $10K | Budget |
| 18 | APL SWIFT SERVICES (… | Malta | $44K | $15K | Budget |
| 19 | 4LIFE HEALTHCARE INC | Philippines | $43K | $14K | Budget |
| 20 | ADK PHARMACEUTICAL C… | Maldives | $29K | $15K | Budget |
| 21 | SUNSHINE HEALTHCARE … | Sri Lanka | $28K | $7K | Budget |
| 22 | OMAN PHARMACEUTICAL … | Oman | $26K | $26K | Mid |
| 23 | 2CARE4 GENERICS APS | Denmark | $22K | $22K | Mid |
| 24 | CAMBER PHARMACEUTICA… | United States | $21K | $21K | Mid |
| 25 | TECNIMEDE-SOCIEDADE … | Portugal | $19K | $19K | Mid |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 ABBOTT HEALTHCARE PVT LTD → MYLAN HUNGARY KFT is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian fenofibrate prices vary by supplier, country and dosage form
KEY TAKEAWAY
Fenofibrate prices span 336400× ($0.0002 → $71.37). The coefficient of variation is 2.92. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0002 | Lowest observed unit price |
| P5 | $0.016 | 5th percentile |
| P25 | $0.039 | 25th percentile (Q1) |
| Median | $0.715 | 50th percentile (Q2) |
| P75 | $2.90 | 75th percentile (Q3) |
| P95 | $18.18 | 95th percentile |
| Max | $71.37 | Highest observed unit price |
| Mean | $4.65 | Arithmetic average |
| CV | 292% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 ABBOTT HEALTHCARE PVT LTD prices at $54.38/unit vs market median $0.715.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. CIPLA LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ABBOTT HEALTHCARE PVT Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. MYLAN LABORATORIES LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. MICRO LABS LTD Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | ATHENA DRUG DELI… | South Korea | Pellets | 3K | $548K | $195.58 | Specialty / small-batch |
| Oct 2025 | COHANCE LIFESCIE… | Brazil | Other | 1K | $137K | $104.50 | Specialty / small-batch |
| Dec 2025 | SAVA HEALTHCARE … | Mauritius | Tablet | 1 | $71.37 | $71.37 | Specialty / small-batch |
| Dec 2025 | ABBOTT HEALTHCAR… | Hungary | Tablet | 3K | $197K | $67.47 | Specialty / small-batch |
| Dec 2025 | ABBOTT HEALTHCAR… | Hungary | Tablet | 4K | $246K | $67.43 | Specialty / small-batch |
| Dec 2025 | ABBOTT HEALTHCAR… | Hungary | Tablet | 4K | $246K | $67.42 | Specialty / small-batch |
| Dec 2025 | ABBOTT HEALTHCAR… | Hungary | Tablet | 4K | $244K | $67.39 | Specialty / small-batch |
| Dec 2025 | ABBOTT HEALTHCAR… | Slovenia | Tablet | 4K | $240K | $66.09 | Specialty / small-batch |
| Nov 2025 | ABBOTT HEALTHCAR… | Slovenia | Tablet | 4K | $240K | $66.00 | Specialty / small-batch |
| Nov 2025 | ABBOTT HEALTHCAR… | Slovenia | Tablet | 4K | $238K | $65.57 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | NARAYANA HRUDAYA… | Cayman Islands | Tablet | 300 | $2.05 | $0.0068 | Bulk generic tablet |
| Nov 2025 | ABBOTT HEALTHCAR… | France | Tablet | 45K | $434.09 | $0.0096 | Bulk generic tablet |
| Nov 2025 | ABBOTT HEALTHCAR… | France | Tablet | 45K | $434.09 | $0.0096 | Bulk generic tablet |
| Dec 2025 | RAVIAN LIFE SCIE… | Philippines | Tablet | 978 | $12.81 | $0.013 | Small sample / trial shipment |
| Dec 2025 | RAVIAN LIFE SCIE… | Philippines | Tablet | 2K | $26.01 | $0.013 | |
| Dec 2025 | ATHENA DRUG DELI… | United Kingdom | Tablet | 31K | $405.12 | $0.013 | |
| Nov 2025 | ALEMBIC PHARMACE… | United States | Capsule | 1.5M | $23K | $0.016 | Bulk volume discount |
| Nov 2025 | ALEMBIC PHARMACE… | United States | Capsule | 1.5M | $24K | $0.016 | Bulk volume discount |
| Nov 2025 | ALEMBIC PHARMACE… | United States | Capsule | 1.5M | $24K | $0.016 | Bulk volume discount |
| Oct 2025 | ALEMBIC PHARMACE… | United States | Capsule | 1.4M | $24K | $0.016 | Bulk volume discount |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship fenofibrate, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Fenofibrate leaves India through 15+ ports. The top 5 (CHAWAPAYAL ICD, MUMBAI AIR (SAHAR), NHAVA SHEVA SEA (JNPT)) handle 92.5% of total USD. ICD moves 20% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 CHAWAPAYAL ICD handles $2.0M — top 15 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 KOPER is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
ICD dominates at 20% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
ICD
$3.0M
46.8% of USD · 19.5% of ships
SEA
$1.8M
28.8% of USD · 38.6% of ships
AIR
$1.5M
24.4% of USD · 41.9% of ships
Fig 8.3 The dominant corridor is CHAWAPAYAL ICD → Sea → Europe ($2.0M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Germany is the most concentrated destination (HHI 10000, 1 suppliers). United States is the most competitive (HHI 1739).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Germany (HHI 10,000) is the most concentrated — United States (HHI 1,739) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 19 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MYLAN HUNGARY KFT | Hungary | ABBOTT HEALTHCAR… | $2.0M | 9 | CRITICAL |
| HANLIM PHARM. CO LTD | South Korea | ATHENA DRUG DELI… | $548K | 1 | CRITICAL |
| CIPLA USA INC | United States | CIPLA LTD | $359K | 19 | HIGH |
| ARROW PHARMACEUTICAL… | Australia | CIPLA LTD | $339K | 6 | HIGH |
| AMNEAL PHARMACEUTICA… | United States | AMNEAL PHARMACEU… | $329K | 6 | HIGH |
| SADDOZ PTY LTD | Australia | HETERO LABS LTD | $269K | 4 | HIGH |
| J. KNIPPER & COMPANY | United States | ALEMBIC PHARMACE… | $163K | 11 | HIGH |
| COMEXPORT TRADING CO… | Brazil | COHANCE LIFESCIE… | $137K | 1 | HIGH |
Conclusion: 48 buyers depend on exactly one Indian supplier, representing $5.4M in trade. 2 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Hungary | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Slovenia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| South Korea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Belgium | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Germany | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Malta | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Panama | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Saudi Arabia | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Maldives | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 12 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Hungary | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Germany lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Hungary (1 suppliers) | This Q | HIGH |
| A6 | Enter Malaysia (2 suppliers) | This Q | MED |
| A8 | Build Hungary distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (ATHENA DRUG) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Hungary | Other | 1 | $1.3M | +286.9% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Malaysia | Asia | 2 | $4K | +21686.6% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Australia | Other | 2 | $607K | +26.1% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Slovenia | Other | 1 | $719K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | South Korea | Asia | 1 | $548K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Brazil | Other | 2 | $151K | -99.9% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Belgium | Other | 1 | $125K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Germany | Other | 1 | $117K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | United Kingdom | Other | 2 | $95K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Malta | Other | 2 | $75K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Panama | Other | 1 | $75K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Saudi Arabia | Other | 1 | $68K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Philippines | Asia | 3 | $56K | -71.4% | LOW | Low competition (3 suppliers), accessible market |
| 14 | Maldives | Asia | 2 | $35K | -22.9% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Sri Lanka | Asia | 1 | $28K | -96.1% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 241 2025-Q4 Fenofibrate shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/fenofibrate
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 241 2025-Q4 fenofibrate shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian fenofibrate shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
241
across all regions
TOTAL USD
$6.33M
2025-Q4 FOB value
UNITS
64.2M
tablets, capsules, etc.
SUPPLIERS
46
Indian exporters
BUYERS
51
global importers
COUNTRIES
40
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $21K (0.3%), spanning 9 countries.
46 Indian suppliers shipped to 51 buyers across 40 countries — average shipment value $26K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
9 countries · 20 shipments · $21K · 12 Indian suppliers · 9 buyers
SHIPMENTS
20
USD
$21K
COUNTRIES
9
SUPPLIERS
12
BUYERS
9
HHI
4,777
concentrated
Top 9 destination countries in Africa
1
Nigeria (62.3%)
$13K
2
Sierra Leone (30.8%)
$7K
3
Ghana (3.7%)
$787.83
4
Mauritius (1.7%)
$362.23
5
Ethiopia (0.9%)
$201.94
6
South Africa (0.4%)
$95.84
7
Zambia (0.1%)
$20.10
8
Seychelles (0.0%)
$4.17
9
Somalia (0.0%)
$2.38
Top 12 Indian suppliers into Africa
1
BHARAT PARENTERALS LTD
$13K
2
TRIOPLUS PHARMACEUTICALS PVT LTD
$7K
3
BAKER & DAVIS PVT LTD
$629.05
4
SAVA HEALTHCARE LTD
$362.23
5
MATOSHREE HEALTH CARE PVT LTD
$201.94
6
MDS ENTERPRISES
$158.77
7
KLV HEALTHCARE PVT LTD
$120.00
8
HANSI TRADERS
$95.84
9
MEDICOS LIFESCIENCES
$20.10
10
AL-SUPREME EXPORTS
$4.17
11
CURE EARTH PHARMA
$1.92
12
DEN MARK PHARMACEUTICALS PVT LTD
$0.458
Top 7 Africa importers
1
M/S.CHANRAIHEALTH CARE LTD · Nigeria
$13K
2
MSJ PHARMACEUTICALS · Sierra Leone
$7K
3
FREIGHTER MADE LOGISTICS LTD · Ghana
$429.40
4
REGENCY EXIM TRADE LTD · Mauritius
$362.23
5
LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia
$20.10
6
GOOD HEALTH (PTY) LTD · Seychelles
$4.17
7
KALKAAL HOSPITAL · Somalia
$1.92
Top 2 dosage forms
1
Tablet
$21K
2
Capsule
$95.84
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $13K | $7K |
| Nov | 7 | $7K | $1K |
| Dec | 11 | $708.89 | $64.44 |
Shipment register · 20 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BHARAT PARENTERALS LTD · 1 shipments · $13K | |||||||||||
| 1 | Oct 2025 | M/S.CHANRAIHEALTH CARE LTD | Nigeria | Tablet | 10.0K | NOS | $1.32 | $13K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA |
| SUPPLIER #2 — TRIOPLUS PHARMACEUTICALS PVT LTD · 1 shipments · $7K | |||||||||||
| 2 | Nov 2025 | MSJ PHARMACEUTICALS | Sierra Leone | Tablet | 10.0K | PCS | $0.659 | $7K | CHAWAPAYAL ICD | FREETOWN | ICD |
| SUPPLIER #3 — BAKER & DAVIS PVT LTD · 4 shipments · $629.05 | |||||||||||
| 3 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 2.0K | NOS | $0.100 | $199.66 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Ghana | Tablet | 2.0K | NOS | $0.100 | $199.66 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 5 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 2.0K | NOS | $0.100 | $199.77 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 6 | Nov 2025 | FREIGHTER MADE LOGISTICS LTD | Ghana | Tablet | 300 | NOS | $0.100 | $29.97 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #4 — SAVA HEALTHCARE LTD · 5 shipments · $362.23 | |||||||||||
| 7 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 2 | NOS | $18.18 | $36.37 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 8 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 8 | NOS | $18.18 | $145.46 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 9 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $71.37 | $71.37 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 10 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 2 | NOS | $18.17 | $36.34 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 11 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 4 | NOS | $18.17 | $72.69 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #5 — MATOSHREE HEALTH CARE PVT LTD · 1 shipments · $201.94 | |||||||||||
| 12 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Tablet | 1.0K | NOS | $0.202 | $201.94 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #6 — MDS ENTERPRISES · 1 shipments · $158.77 | |||||||||||
| 13 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 25 | NOS | $6.35 | $158.77 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #7 — KLV HEALTHCARE PVT LTD · 1 shipments · $120.00 | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Nigeria | Tablet | 1.0K | NOS | $0.120 | $120.00 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #8 — HANSI TRADERS · 1 shipments · $95.84 | |||||||||||
| 15 | Nov 2025 | UNKNOWN BUYER | South Africa | Capsule | 400 | NOS | $0.240 | $95.84 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #9 — MEDICOS LIFESCIENCES · 1 shipments · $20.10 | |||||||||||
| 16 | Dec 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Tablet | 100 | NOS | $0.201 | $20.10 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #10 — AL-SUPREME EXPORTS · 1 shipments · $4.17 | |||||||||||
| 17 | Dec 2025 | GOOD HEALTH (PTY) LTD | Seychelles | Tablet | 100 | NOS | $0.042 | $4.17 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #11 — CURE EARTH PHARMA · 1 shipments · $1.92 | |||||||||||
| 18 | Oct 2025 | KALKAAL HOSPITAL | Somalia | Tablet | 1 | NOS | $1.92 | $1.92 | CHENNAI AIR | MOGADISCHU | AIR |
| SUPPLIER #12 — DEN MARK PHARMACEUTICALS PVT LTD · 2 shipments · $0.458 | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 20 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Berbera | SEA |
| 20 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 20 | NOS | $0.023 | $0.458 | NHAVA SHEVA SEA (JNPT) | Berbera | SEA |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
12 countries · 59 shipments · $797K · 17 Indian suppliers · 15 buyers
SHIPMENTS
59
USD
$797K
COUNTRIES
12
SUPPLIERS
17
BUYERS
15
HHI
4,920
concentrated
Top 12 destination countries in Asia
1
South Korea (68.7%)
$548K
2
Saudi Arabia (8.5%)
$68K
3
Philippines (7.0%)
$56K
4
Maldives (4.4%)
$35K
5
Sri Lanka (3.6%)
$28K
6
Oman (3.2%)
$26K
7
Turkey (2.1%)
$16K
8
Myanmar (1.2%)
$10K
9
Malaysia (0.5%)
$4K
10
Vietnam (0.5%)
$4K
11
Cambodia (0.2%)
$2K
12
United Arab Emirates (0.1%)
$940.71
Top 17 Indian suppliers into Asia
1
ATHENA DRUG DELIVERY SOLUTIONS PVT LTD
$548K
2
HETERO LABS LTD
$94K
3
SASHA LIFE HEALTHCARE
$43K
4
MICRO LABS LTD
$29K
5
ZYDUS LIFESCIENCES LTD
$28K
6
SCOTT EDIL PHARMACIA LTD
$16K
7
XL LABORATORIES PVT LTD
$12K
8
SAGA LIFESCIENCES LTD
$8K
9
TROIKAA PHARMACEUTICALS LTD
$6K
10
HIGHKON PHARMA
$6K
11
MACLEODS PHARMACEUTICALS LTD
$4K
12
PHARMA ALACRITY LLP
$2K
13
DERRIC WOOD
$829.07
14
FALCON TRANSGLOBAL
$64.42
15
LAWRENCE WALTER
$47.22
16
RAVIAN LIFE SCIENCE PVT LTD
$38.82
17
BABA AGENCIES
$18.36
Top 13 Asia importers
1
HANLIM PHARM. CO LTD · South Korea
$548K
2
4LIFE HEALTHCARE INC · Philippines
$43K
3
ADK PHARMACEUTICAL COMPANY PVT LTD · Maldives
$29K
4
SUNSHINE HEALTHCARE LANKA LTD · Sri Lanka
$28K
5
OMAN PHARMACEUTICAL PRODUCTS CO LLC · Oman
$26K
6
AMBICA INTERNATIONAL CORP · Philippines
$12K
7
A.P.C. (P) L · Maldives
$6K
8
DKSH MALAYSIA SDN BHD · Malaysia
$4K
9
STANLEY BIOTECH COMPANY LTD · Myanmar
$2K
10
EMIRATES POST COMPANY · United Arab Emirates
$771.78
11
EMIRATES POST GROUP · United Arab Emirates
$64.42
12
PHARMAKON BIOTEC INC · Philippines
$38.82
13
VITAL RANK SDN BHD · Malaysia
$18.36
Top 4 dosage forms
1
Pellets
$548K
2
Tablet
$136K
3
Capsule
$113K
4
Unknown
$19.08
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 11 | $114K | $10K |
| Nov | 24 | $28K | $1K |
| Dec | 24 | $656K | $27K |
Shipment register · 59 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ATHENA DRUG DELIVERY SOLUTIONS PVT LTD · 1 shipments · $548K | |||||||||||
| 1 | Dec 2025 | HANLIM PHARM. CO LTD | South Korea | Pellets | 2.8K | KGS | $195.58 | $548K | MUMBAI AIR (SAHAR) | SEOUL - INCHEON INT' | AIR |
| SUPPLIER #2 — HETERO LABS LTD · 4 shipments · $94K | |||||||||||
| 2 | Oct 2025 | OMAN PHARMACEUTICAL PRODUCTS CO LLC | Oman | Tablet | 379.2K | NOS | $0.068 | $26K | HYDERABAD AIR | MUSCAT | AIR |
| 3 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Tablet | 10.1K | NOS | $0.405 | $4K | HYDERABAD ICD | DAMMAM | ICD |
| 4 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Tablet | 1.0M | NOS | $0.041 | $41K | HYDERABAD ICD | DAMMAM | ICD |
| 5 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Tablet | 552.0K | NOS | $0.041 | $22K | HYDERABAD ICD | DAMMAM | ICD |
| SUPPLIER #3 — SASHA LIFE HEALTHCARE · 3 shipments · $43K | |||||||||||
| 6 | Oct 2025 | 4LIFE HEALTHCARE INC | Philippines | Capsule | 9.8K | NOS | $1.12 | $11K | AHMEDABAD AIR | MANILA | AIR |
| 7 | Oct 2025 | 4LIFE HEALTHCARE INC | Philippines | Capsule | 9.8K | NOS | $1.12 | $11K | AHMEDABAD AIR | MANILA | AIR |
| 8 | Oct 2025 | 4LIFE HEALTHCARE INC | Philippines | Capsule | 19.1K | NOS | $1.11 | $21K | AHMEDABAD AIR | MANILA | AIR |
| SUPPLIER #4 — MICRO LABS LTD · 2 shipments · $29K | |||||||||||
| 9 | Oct 2025 | ADK PHARMACEUTICAL COMPANY PVT LTD | Maldives | Capsule | 2.0K | PCS | $9.94 | $20K | BANGALORE AIR | MALE | AIR |
| 10 | Dec 2025 | ADK PHARMACEUTICAL COMPANY PVT LTD | Maldives | Capsule | 900 | PCS | $10.25 | $9K | BANGALORE AIR | MALE | AIR |
| SUPPLIER #5 — ZYDUS LIFESCIENCES LTD · 4 shipments · $28K | |||||||||||
| 11 | Oct 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | Capsule | 972 | PCS | $2.86 | $3K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 12 | Nov 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | Capsule | 3.2K | PCS | $2.86 | $9K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 13 | Nov 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | Capsule | 5.8K | PCS | $2.83 | $16K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 14 | Dec 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | Capsule | 3.4K | PCS | $0.032 | $108.71 | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #6 — SCOTT EDIL PHARMACIA LTD · 1 shipments · $16K | |||||||||||
| 15 | Oct 2025 | UNLISTED BUYER | Turkey | Tablet | 90.0K | NOS | $0.182 | $16K | MUNDRA SEA | Mersin | SEA |
| SUPPLIER #7 — XL LABORATORIES PVT LTD · 1 shipments · $12K | |||||||||||
| 16 | Dec 2025 | AMBICA INTERNATIONAL CORP | Philippines | Capsule | 6.1K | NOS | $2.04 | $12K | DELHI AIR | MANILA | AIR |
| SUPPLIER #8 — SAGA LIFESCIENCES LTD · 1 shipments · $8K | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Myanmar | Tablet | 2.5K | NOS | $3.13 | $8K | AHMEDABAD AIR | YANGON | AIR |
| SUPPLIER #9 — TROIKAA PHARMACEUTICALS LTD · 1 shipments · $6K | |||||||||||
| 18 | Dec 2025 | A.P.C. (P) L | Maldives | Tablet | 2.0K | NOS | $3.05 | $6K | DELHI AIR | MALE | AIR |
| SUPPLIER #10 — HIGHKON PHARMA · 3 shipments · $6K | |||||||||||
| 19 | Oct 2025 | UNKNOWN BUYER | Cambodia | Tablet | 5.1K | NOS | $0.372 | $2K | TUGHLAKABAD ICD | Sihanoukville (Kompo | ICD |
| 20 | Oct 2025 | UNKNOWN BUYER | Vietnam | Tablet | 5.1K | NOS | $0.372 | $2K | TUGHLAKABAD ICD | Ho Chi Minh City | ICD |
| 21 | Oct 2025 | UNKNOWN BUYER | Vietnam | Tablet | 5.1K | NOS | $0.372 | $2K | TUGHLAKABAD ICD | Ho Chi Minh City | ICD |
| SUPPLIER #11 — MACLEODS PHARMACEUTICALS LTD · 2 shipments · $4K | |||||||||||
| 22 | Dec 2025 | DKSH MALAYSIA SDN BHD | Malaysia | Tablet | 48.6K | NOS | $0.082 | $4K | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| 23 | Dec 2025 | DKSH MALAYSIA SDN BHD | Malaysia | Tablet | 9.9K | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #12 — PHARMA ALACRITY LLP · 1 shipments · $2K | |||||||||||
| 24 | Nov 2025 | STANLEY BIOTECH COMPANY LTD | Myanmar | Tablet | 1.2K | NOS | $1.46 | $2K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| SUPPLIER #13 — DERRIC WOOD · 26 shipments · $829.07 | |||||||||||
| 25 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.92 | $26.32 | DELHI AIR | DUBAI | AIR |
| 26 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.92 | $26.32 | DELHI AIR | DUBAI | AIR |
| 27 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.90 | $26.13 | DELHI AIR | DUBAI | AIR |
| 28 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 9 | PCS | $2.90 | $26.13 | DELHI AIR | DUBAI | AIR |
| 29 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.90 | $26.13 | DELHI AIR | DUBAI | AIR |
| 30 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 9 | PCS | $2.90 | $26.13 | DELHI AIR | DUBAI | AIR |
| 31 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.90 | $26.13 | DELHI AIR | DUBAI | AIR |
| 32 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.90 | $26.13 | DELHI AIR | DUBAI | AIR |
| 33 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 9 | PCS | $2.90 | $26.13 | DELHI AIR | DUBAI | AIR |
| 34 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 9 | PCS | $2.90 | $26.13 | DELHI AIR | DUBAI | AIR |
| 35 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 9 | PCS | $2.78 | $25.03 | DELHI AIR | DUBAI | AIR |
| 36 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $2.93 | $17.58 | DELHI AIR | DUBAI | AIR |
| 37 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.93 | $26.38 | DELHI AIR | DUBAI | AIR |
| 38 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.27 | $20.42 | DELHI AIR | DUBAI | AIR |
| 39 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 30 | PCS | $2.94 | $88.27 | DELHI AIR | DUBAI | AIR |
| 40 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $2.28 | $40.97 | DELHI AIR | DUBAI | AIR |
| 41 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.92 | $26.32 | DELHI AIR | DUBAI | AIR |
| 42 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $2.28 | $40.95 | DELHI AIR | DUBAI | AIR |
| 43 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 18 | PCS | $2.94 | $52.85 | DELHI AIR | DUBAI | AIR |
| 44 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $3.00 | $27.04 | DELHI AIR | DUBAI | AIR |
| 45 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $2.34 | $42.07 | DELHI AIR | DUBAI | AIR |
| 46 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 18 | PCS | $3.02 | $54.29 | DELHI AIR | DUBAI | AIR |
| 47 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 36 | PCS | $2.92 | $104.97 | DELHI AIR | DUBAI | AIR |
| 48 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 49 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.022 | $0.131 | DELHI AIR | DUBAI | AIR |
| 50 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.022 | $0.131 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #14 — FALCON TRANSGLOBAL · 3 shipments · $64.42 | |||||||||||
| 51 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 10 | NOS | $2.39 | $23.85 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 52 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | 8 | NOS | $2.39 | $19.08 | MUMBAI AIR (SAHAR) | DUBAI | AIR | |
| 53 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 9 | NOS | $2.39 | $21.49 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #15 — LAWRENCE WALTER · 3 shipments · $47.22 | |||||||||||
| 54 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 10 | PCS | $2.36 | $23.60 | DELHI AIR | DUBAI | AIR |
| 55 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 5 | PCS | $2.36 | $11.81 | DELHI AIR | DUBAI | AIR |
| 56 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 5 | PCS | $2.36 | $11.81 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #16 — RAVIAN LIFE SCIENCE PVT LTD · 2 shipments · $38.82 | |||||||||||
| 57 | Dec 2025 | PHARMAKON BIOTEC INC | Philippines | Tablet | 978 | NOS | $0.013 | $12.81 | DELHI AIR | MANILA | AIR |
| 58 | Dec 2025 | PHARMAKON BIOTEC INC | Philippines | Tablet | 2.0K | NOS | $0.013 | $26.01 | DELHI AIR | MANILA | AIR |
| SUPPLIER #17 — BABA AGENCIES · 1 shipments · $18.36 | |||||||||||
| 59 | Oct 2025 | VITAL RANK SDN BHD | Malaysia | Tablet | 60 | NOS | $0.306 | $18.36 | CHENNAI AIR | KUALA LUMPUR - INT'L | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
9 countries · 35 shipments · $2.49M · 4 Indian suppliers · 10 buyers
SHIPMENTS
35
USD
$2.49M
COUNTRIES
9
SUPPLIERS
4
BUYERS
10
HHI
6,823
concentrated
Top 9 destination countries in Europe
1
Hungary (52.9%)
$1.32M
2
Slovenia (28.9%)
$719K
3
Belgium (5.0%)
$125K
4
Germany (4.7%)
$117K
5
United Kingdom (3.8%)
$95K
6
Malta (3.0%)
$75K
7
Denmark (0.9%)
$22K
8
Portugal (0.8%)
$19K
9
France (0.0%)
$868.18
Top 4 Indian suppliers into Europe
1
ABBOTT HEALTHCARE PVT LTD
$2.04M
2
TORRENT PHARMACEUTICALS LTD
$243K
3
SUN PHARMACEUTICAL INDUSTRIES LTD
$125K
4
ATHENA DRUG DELIVERY SOLUTIONS PVT LTD
$86K
Top 9 Europe importers
1
MYLAN HUNGARY KFT · Hungary
$2.03M
2
YUSEN LOGISTICS BENELUX BELGIUM · Belgium
$125K
3
HEUMANN PHARMA GMBH · Malta
$110K
4
TORRENT PHARMA (UK) LTD · United Kingdom
$95K
5
APL SWIFT SERVICES (MALTA) LTD · Malta
$44K
6
2CARE4 GENERICS APS · Denmark
$22K
7
TECNIMEDE-SOCIEDADE TCNICO-MEDICIN · Portugal
$19K
8
ASTREA FONTAINE SAS · France
$434.09
9
CRESCENT PHARMA LTD · United Kingdom
$405.12
Top 3 dosage forms
1
Tablet
$2.34M
2
Capsule
$132K
3
film-coated tablet
$16K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $349K | $50K |
| Nov | 18 | $925K | $51K |
| Dec | 10 | $1.21M | $121K |
Shipment register · 35 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ABBOTT HEALTHCARE PVT LTD · 11 shipments · $2.04M | |||||||||||
| 1 | Oct 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 3.7K | KGS | $65.33 | $241K | CHAWAPAYAL ICD | KOPER | ICD |
| 2 | Nov 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 2.2K | KGS | $65.43 | $141K | CHAWAPAYAL ICD | KOPER | ICD |
| 3 | Nov 2025 | MYLAN HUNGARY KFT | Slovenia | Tablet | 3.6K | KGS | $65.57 | $238K | CHAWAPAYAL ICD | KOPER | ICD |
| 4 | Nov 2025 | ASTREA FONTAINE SAS | France | Tablet | 45.1K | TBS | $0.0096 | $434.09 | DELHI AIR | PARIS - CHARLES DE G | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | France | Tablet | 45.1K | TBS | $0.0096 | $434.09 | DELHI AIR | PARIS - CHARLES DE G | AIR |
| 6 | Nov 2025 | MYLAN HUNGARY KFT | Slovenia | Tablet | 3.6K | KGS | $66.00 | $240K | CHAWAPAYAL ICD | KOPER | ICD |
| 7 | Dec 2025 | MYLAN HUNGARY KFT | Slovenia | Tablet | 3.6K | KGS | $66.09 | $240K | CHAWAPAYAL ICD | KOPER | ICD |
| 8 | Dec 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 3.7K | KGS | $67.42 | $246K | CHAWAPAYAL ICD | KOPER | ICD |
| 9 | Dec 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 3.6K | KGS | $67.39 | $244K | CHAWAPAYAL ICD | KOPER | ICD |
| 10 | Dec 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 3.6K | KGS | $67.43 | $246K | CHAWAPAYAL ICD | KOPER | ICD |
| 11 | Dec 2025 | MYLAN HUNGARY KFT | Hungary | Tablet | 2.9K | KGS | $67.47 | $197K | CHAWAPAYAL ICD | KOPER | ICD |
| SUPPLIER #2 — TORRENT PHARMACEUTICALS LTD · 13 shipments · $243K | |||||||||||
| 12 | Nov 2025 | HEUMANN PHARMA GMBH | Malta | Tablet | 340.5K | NOS | $0.045 | $15K | DELHI AIR | MALTA | AIR |
| 13 | Nov 2025 | HEUMANN PHARMA GMBH | Germany | Tablet | 3.4K | NOS | $5.65 | $19K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 14 | Nov 2025 | UNKNOWN BUYER | Germany | Tablet | 3.4K | NOS | $5.65 | $19K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 15 | Nov 2025 | UNKNOWN BUYER | Germany | Tablet | 3.4K | NOS | $5.65 | $19K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 16 | Nov 2025 | HEUMANN PHARMA GMBH | Malta | film-coated tablet | 334.5K | NOS | $0.047 | $16K | DELHI AIR | MALTA | AIR |
| 17 | Nov 2025 | HEUMANN PHARMA GMBH | Germany | Tablet | 3.4K | NOS | $5.71 | $19K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 18 | Nov 2025 | TORRENT PHARMA (UK) LTD | United Kingdom | Tablet | 11.9K | NOS | $1.57 | $19K | NHAVA SHEVA SEA (JNPT) | Southampton | SEA |
| 19 | Nov 2025 | TORRENT PHARMA (UK) LTD | United Kingdom | Tablet | 24.2K | NOS | $1.57 | $38K | NHAVA SHEVA SEA (JNPT) | Southampton | SEA |
| 20 | Nov 2025 | TORRENT PHARMA (UK) LTD | United Kingdom | Tablet | 24.1K | NOS | $1.57 | $38K | NHAVA SHEVA SEA (JNPT) | Southampton | SEA |
| 21 | Dec 2025 | HEUMANN PHARMA GMBH | Germany | Tablet | 3.4K | NOS | $5.72 | $20K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 22 | Dec 2025 | HEUMANN PHARMA GMBH | Germany | Tablet | 1.7K | NOS | $1.89 | $3K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 23 | Dec 2025 | HEUMANN PHARMA GMBH | Germany | Tablet | 2.4K | NOS | $5.92 | $14K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 24 | Dec 2025 | HEUMANN PHARMA GMBH | Germany | Tablet | 960 | NOS | $3.01 | $3K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| SUPPLIER #3 — SUN PHARMACEUTICAL INDUSTRIES LTD · 5 shipments · $125K | |||||||||||
| 25 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 9.5K | PCS | $1.18 | $11K | DHANNAD ICD | ANTWERPEN | ICD |
| 26 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 20.5K | PCS | $1.97 | $41K | DADRI ICD | ANTWERPEN | ICD |
| 27 | Oct 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 14.6K | PCS | $0.842 | $12K | DHANNAD ICD | ANTWERPEN | ICD |
| 28 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Capsule | 20.1K | PCS | $1.17 | $24K | DHANNAD ICD | ANTWERPEN | ICD |
| 29 | Nov 2025 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | Tablet | 21.0K | PCS | $1.76 | $37K | DELHI AIR | BRUSSELS | AIR |
| SUPPLIER #4 — ATHENA DRUG DELIVERY SOLUTIONS PVT LTD · 6 shipments · $86K | |||||||||||
| 30 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Capsule | 8.0K | NOS | $1.02 | $8K | NHAVA SHEVA SEA (JNPT) | MARSAXLOKK | SEA |
| 31 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Capsule | 5.3K | NOS | $3.85 | $21K | NHAVA SHEVA SEA (JNPT) | MARSAXLOKK | SEA |
| 32 | Oct 2025 | APL SWIFT SERVICES (MALTA) LTD | Malta | Capsule | 10.7K | NOS | $1.45 | $15K | NHAVA SHEVA SEA (JNPT) | MARSAXLOKK | SEA |
| 33 | Nov 2025 | 2CARE4 GENERICS APS | Denmark | Capsule | 4.9K | NOS | $4.52 | $22K | MUMBAI AIR (SAHAR) | COPENHAGEN | AIR |
| 34 | Nov 2025 | TECNIMEDE-SOCIEDADE TCNICO-MEDICIN | Portugal | Capsule | 10.6K | NOS | $1.78 | $19K | MUMBAI AIR (SAHAR) | LISBON | AIR |
| 35 | Dec 2025 | CRESCENT PHARMA LTD | United Kingdom | Tablet | 30.9K | NOS | $0.013 | $405.12 | NHAVA SHEVA SEA (JNPT) | Southampton | SEA |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
8 countries · 116 shipments · $2.41M · 16 Indian suppliers · 20 buyers
SHIPMENTS
116
USD
$2.41M
COUNTRIES
8
SUPPLIERS
16
BUYERS
20
HHI
1,578
moderate
Top 8 destination countries in Americas
1
United States (89.4%)
$2.16M
2
Brazil (6.3%)
$151K
3
Panama (3.1%)
$75K
4
Peru (0.8%)
$19K
5
Dominican Republic (0.3%)
$7K
6
Chile (0.2%)
$4K
7
Guyana (0.0%)
$696.53
8
Cayman Islands (0.0%)
$305.54
Top 16 Indian suppliers into Americas
1
CIPLA LTD
$638K
2
HETERO LABS LTD
$497K
3
AMNEAL PHARMACEUTICALS PVT LTD
$329K
4
MANKIND PHARMA LTD
$226K
5
ALEMBIC PHARMACEUTICALS LTD
$220K
6
INVENTIA HEALTHCARE LTD
$150K
7
COHANCE LIFESCIENCES LTD
$137K
8
MYLAN LABORATORIES LTD
$105K
9
AJANTA PHARMA LTD
$71K
10
TORRENT PHARMACEUTICALS LTD
$14K
11
THE MADRAS PHARMACEUTICALS
$10K
12
XL LABORATORIES PVT LTD
$10K
13
WESTCOAST PHARMACEUTICAL WORKS LTD
$7K
14
PEAK HEALTHCARE
$696.53
15
NARAYANA HRUDAYALAYA LTD
$277.58
16
KALINDI OVERSEAS
$27.96
Top 18 Americas importers
1
CIPLA USA INC · United States
$359K
2
AMNEAL PHARMACEUTICALS LLC · United States
$329K
3
J. KNIPPER & COMPANY · United States
$163K
4
COMEXPORT TRADING COMERCIO EXTERIOR · Brazil
$137K
5
NORTHSTAR DISTRIBUTION CENTER · United States
$117K
6
LIFESTAR PHARMA LLC · United States
$109K
7
MYLAN PHARMACEUTICALS INC · United States
$105K
8
ANIP ACQUISITION COMPANY · United States
$86K
9
AGENCIAS CELMAR · Panama
$75K
10
MCKESSON THIRD PARTY LOGISTICS · United States
$71K
11
CAMBER PHARMACEUTICALS INC · United States
$21K
12
TORRENT DO BRASIL LTDAROD FERNAO DI · Brazil
$14K
13
BONAPHARM S.A · Peru
$10K
14
CAFERMA S.A · Peru
$10K
15
ALEMBIC PHARMACEUTICALS SPA · Chile
$4K
16
TORRENT DO BRASIL LTDA · Brazil
$156.25
17
HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands
$139.81
18
THE PHARMACIST · Cayman Islands
$27.96
Top 3 dosage forms
1
Tablet
$1.73M
2
Capsule
$541K
3
Other
$137K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 41 | $914K | $22K |
| Nov | 47 | $1.18M | $25K |
| Dec | 28 | $323K | $12K |
Shipment register · 116 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CIPLA LTD · 30 shipments · $638K | |||||||||||
| 1 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.042 | $25K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 583.2K | NOS | $0.042 | $25K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 3 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 4 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 5 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 6 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 7 | Nov 2025 | CIPLA USA INC | United States | Tablet | 572.4K | NOS | $0.039 | $22K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 8 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 9 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 10 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 11 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 12 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 13 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 14 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 15 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 572.4K | NOS | $0.039 | $22K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 16 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 17 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 18 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 583.2K | NOS | $0.039 | $23K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 19 | Nov 2025 | CIPLA USA INC | United States | Tablet | 585.4K | NOS | $0.044 | $26K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 20 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.044 | $25K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 21 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.044 | $25K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 22 | Nov 2025 | CIPLA USA INC | United States | Tablet | 581.0K | NOS | $0.044 | $25K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 23 | Nov 2025 | CIPLA USA INC | United States | Tablet | 585.4K | NOS | $0.044 | $25K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 24 | Nov 2025 | CIPLA USA INC | United States | Tablet | 583.2K | NOS | $0.044 | $25K | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 25 | Dec 2025 | CIPLA USA INC | United States | Tablet | 585.4K | NOS | $0.0005 | $290.68 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 26 | Dec 2025 | CIPLA USA INC | United States | Tablet | 585.4K | NOS | $0.0005 | $290.68 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 27 | Dec 2025 | CIPLA USA INC | United States | Tablet | 587.5K | NOS | $0.0005 | $291.75 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 28 | Dec 2025 | CIPLA USA INC | United States | Tablet | 585.4K | NOS | $0.0005 | $290.68 | NHAVA SHEVA SEA (JNPT) | Charleston | SEA |
| 29 | Dec 2025 | AGENCIAS CELMAR | Panama | Capsule | 657.8K | NOS | $0.057 | $37K | NHAVA SHEVA SEA (JNPT) | Manzanillo | SEA |
| 30 | Dec 2025 | AGENCIAS CELMAR | Panama | Capsule | 657.8K | NOS | $0.057 | $37K | NHAVA SHEVA SEA (JNPT) | Manzanillo | SEA |
| SUPPLIER #2 — HETERO LABS LTD · 21 shipments · $497K | |||||||||||
| 31 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 978.5K | NOS | $0.028 | $27K | HYDERABAD ICD | NEW YORK | ICD |
| 32 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 192.2K | NOS | $0.028 | $5K | HYDERABAD ICD | NEW YORK | ICD |
| 33 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 1.2M | NOS | $0.028 | $33K | HYDERABAD ICD | NEW YORK | ICD |
| 34 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 976.3K | NOS | $0.028 | $27K | HYDERABAD ICD | NEW YORK | ICD |
| 35 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 589.7K | NOS | $0.028 | $16K | HYDERABAD ICD | NEW YORK | ICD |
| 36 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 978.5K | NOS | $0.028 | $27K | HYDERABAD ICD | NEW YORK | ICD |
| 37 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 982.8K | NOS | $0.028 | $27K | HYDERABAD ICD | NEW YORK | ICD |
| 38 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 786.2K | NOS | $0.028 | $22K | HYDERABAD ICD | NEW YORK | ICD |
| 39 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 1.2M | NOS | $0.028 | $33K | HYDERABAD ICD | NEW YORK | ICD |
| 40 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 963.4K | NOS | $0.028 | $27K | HYDERABAD ICD | NEW YORK | ICD |
| 41 | Oct 2025 | CAMBER PHARMACEUTICALS INC | United States | Tablet | 1.3M | NOS | $0.017 | $21K | HYDERABAD AIR | NEWARK, NJ | AIR |
| 42 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 794.9K | NOS | $0.019 | $15K | HYDERABAD ICD | New York | ICD |
| 43 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 486.0K | NOS | $0.019 | $9K | HYDERABAD ICD | New York | ICD |
| 44 | Oct 2025 | UNLISTED BUYER | United States | Tablet | 2.6M | NOS | $0.019 | $49K | HYDERABAD ICD | New York | ICD |
| 45 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 1.3M | NOS | $0.019 | $25K | HYDERABAD ICD | NEW YORK | ICD |
| 46 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 1.3M | NOS | $0.020 | $25K | HYDERABAD ICD | NEW YORK | ICD |
| 47 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 982.8K | NOS | $0.028 | $28K | HYDERABAD ICD | NEW YORK | ICD |
| 48 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 1.3M | NOS | $0.019 | $25K | HYDERABAD ICD | NEW YORK | ICD |
| 49 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 1.3M | NOS | $0.020 | $25K | HYDERABAD ICD | NEW YORK | ICD |
| 50 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 1.3M | NOS | $0.020 | $25K | HYDERABAD ICD | NEW YORK | ICD |
| 51 | Dec 2025 | UNLISTED BUYER | United States | Tablet | 133.9K | NOS | $0.028 | $4K | HYDERABAD ICD | NEW YORK | ICD |
| SUPPLIER #3 — AMNEAL PHARMACEUTICALS PVT LTD · 6 shipments · $329K | |||||||||||
| 52 | Oct 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 4.7K | NOS | $11.43 | $53K | MUNDRA SEA | SAVANNAH | SEA |
| 53 | Oct 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 1.2K | NOS | $11.43 | $13K | MUNDRA SEA | SAVANNAH | SEA |
| 54 | Oct 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 19.6K | NOS | $2.15 | $42K | MUNDRA SEA | SAVANNAH | SEA |
| 55 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 25.6K | NOS | $2.15 | $55K | MUNDRA SEA | Savannah | SEA |
| 56 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 3.5K | NOS | $11.38 | $40K | MUNDRA SEA | Savannah | SEA |
| 57 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 57.9K | NOS | $2.15 | $124K | MUNDRA SEA | Savannah | SEA |
| SUPPLIER #4 — MANKIND PHARMA LTD · 16 shipments · $226K | |||||||||||
| 58 | Oct 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 9.2K | NOS | $1.61 | $15K | MUNDRA SEA | NORFOLK | SEA |
| 59 | Oct 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 9.2K | NOS | $1.61 | $15K | MUNDRA SEA | NORFOLK | SEA |
| 60 | Oct 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 11.4K | NOS | $0.902 | $10K | MUNDRA SEA | NORFOLK | SEA |
| 61 | Oct 2025 | NORTHSTAR DISTRIBUTION CENTER | United States | Tablet | 9.3K | NOS | $1.60 | $15K | MUNDRA SEA | NORFOLK | SEA |
| 62 | Oct 2025 | NORTHSTAR DISTRIBUTION CENTER | United States | Tablet | 1.7K | NOS | $8.40 | $14K | MUNDRA SEA | NORFOLK | SEA |
| 63 | Oct 2025 | NORTHSTAR DISTRIBUTION CENTER | United States | Tablet | 9.2K | NOS | $1.60 | $15K | MUNDRA SEA | NORFOLK | SEA |
| 64 | Oct 2025 | NORTHSTAR DISTRIBUTION CENTER | United States | Tablet | 9.2K | NOS | $1.60 | $15K | MUNDRA SEA | NORFOLK | SEA |
| 65 | Oct 2025 | NORTHSTAR DISTRIBUTION CENTER | United States | Tablet | 15.9K | NOS | $0.896 | $14K | MUNDRA SEA | NORFOLK | SEA |
| 66 | Oct 2025 | NORTHSTAR DISTRIBUTION CENTER | United States | Tablet | 9.2K | NOS | $1.60 | $15K | MUNDRA SEA | NORFOLK | SEA |
| 67 | Oct 2025 | NORTHSTAR DISTRIBUTION CENTER | United States | Tablet | 9.2K | NOS | $1.60 | $15K | MUNDRA SEA | NORFOLK | SEA |
| 68 | Oct 2025 | NORTHSTAR DISTRIBUTION CENTER | United States | Tablet | 9.2K | NOS | $1.60 | $15K | MUNDRA SEA | NORFOLK | SEA |
| 69 | Oct 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.6K | NOS | $8.38 | $14K | MUNDRA SEA | Norfolk | SEA |
| 70 | Oct 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.7K | NOS | $8.38 | $14K | MUNDRA SEA | Norfolk | SEA |
| 71 | Oct 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.7K | NOS | $8.38 | $14K | MUNDRA SEA | Norfolk | SEA |
| 72 | Oct 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.7K | NOS | $8.38 | $14K | MUNDRA SEA | Norfolk | SEA |
| 73 | Oct 2025 | LIFESTAR PHARMA LLC | United States | Tablet | 1.7K | NOS | $8.38 | $14K | MUNDRA SEA | Norfolk | SEA |
| SUPPLIER #5 — ALEMBIC PHARMACEUTICALS LTD · 14 shipments · $220K | |||||||||||
| 74 | Oct 2025 | J. KNIPPER & COMPANY | United States | Capsule | 802.4K | TBS | $0.037 | $29K | MUNDRA SEA | NORFOLK | SEA |
| 75 | Oct 2025 | J. KNIPPER & COMPANY | United States | Capsule | 1.4M | NOS | $0.016 | $24K | MUNDRA SEA | Charleston | SEA |
| 76 | Nov 2025 | J. KNIPPER & COMPANY | United States | Capsule | 1.5M | NOS | $0.016 | $23K | MUNDRA SEA | Norfolk | SEA |
| 77 | Nov 2025 | J. KNIPPER & COMPANY | United States | Capsule | 1.5M | NOS | $0.016 | $24K | MUNDRA SEA | New York | SEA |
| 78 | Nov 2025 | UNKNOWN BUYER | United States | Capsule | 1.5M | NOS | $0.016 | $24K | MUNDRA SEA | New York | SEA |
| 79 | Nov 2025 | UNKNOWN BUYER | United States | Capsule | 1.2M | NOS | $0.025 | $30K | MUNDRA SEA | New York | SEA |
| 80 | Nov 2025 | J. KNIPPER & COMPANY | United States | Capsule | 316.8K | NOS | $0.019 | $6K | MUNDRA SEA | Norfolk | SEA |
| 81 | Nov 2025 | J. KNIPPER & COMPANY | United States | Capsule | 159.6K | NOS | $0.019 | $3K | MUNDRA SEA | Norfolk | SEA |
| 82 | Dec 2025 | ALEMBIC PHARMACEUTICALS SPA | Chile | Capsule | 142.0K | NOS | $0.027 | $4K | DELHI AIR | SANTIAGO DE CHILE - | AIR |
| 83 | Dec 2025 | J. KNIPPER & COMPANY | United States | Capsule | 1.5M | NOS | $0.017 | $24K | MUNDRA SEA | Norfolk | SEA |
| 84 | Dec 2025 | J. KNIPPER & COMPANY | United States | Capsule | 157.2K | NOS | $0.0002 | $33.11 | MUNDRA SEA | Norfolk | SEA |
| 85 | Dec 2025 | J. KNIPPER & COMPANY | United States | Capsule | 154.8K | NOS | $0.0002 | $32.70 | MUNDRA SEA | Norfolk | AIR |
| 86 | Dec 2025 | J. KNIPPER & COMPANY | United States | Capsule | 319.2K | TBS | $0.0002 | $67.72 | MUNDRA SEA | Norfolk | SEA |
| 87 | Dec 2025 | J. KNIPPER & COMPANY | United States | Capsule | 1.2M | NOS | $0.026 | $30K | MUNDRA SEA | Norfolk | SEA |
| SUPPLIER #6 — INVENTIA HEALTHCARE LTD · 5 shipments · $150K | |||||||||||
| 88 | Nov 2025 | ANIP ACQUISITION COMPANY | United States | Capsule | 668.4K | NOS | $0.033 | $22K | MUMBAI AIR (SAHAR) | CHICAGO O'HARE INT'L | AIR |
| 89 | Nov 2025 | ANIP ACQUISITION COMPANY | United States | Capsule | 12.4K | NOS | $2.30 | $29K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 90 | Nov 2025 | ANIP ACQUISITION COMPANY | United States | Capsule | 10.6K | NOS | $3.33 | $35K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 91 | Nov 2025 | UNKNOWN BUYER | United States | Capsule | 12.4K | NOS | $2.30 | $29K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 92 | Nov 2025 | UNKNOWN BUYER | United States | Capsule | 10.6K | NOS | $3.33 | $35K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| SUPPLIER #7 — COHANCE LIFESCIENCES LTD · 1 shipments · $137K | |||||||||||
| 93 | Oct 2025 | COMEXPORT TRADING COMERCIO EXTERIOR | Brazil | Other | 1.3K | KGS | $104.50 | $137K | HYDERABAD AIR | VITORIA | AIR |
| SUPPLIER #8 — MYLAN LABORATORIES LTD · 2 shipments · $105K | |||||||||||
| 94 | Nov 2025 | MYLAN PHARMACEUTICALS INC | United States | Tablet | 1.7M | NOS | $0.033 | $54K | MUMBAI AIR (SAHAR) | ATLANTA, HARTSFIELD | AIR |
| 95 | Nov 2025 | MYLAN PHARMACEUTICALS INC | United States | Tablet | 1.6M | NOS | $0.031 | $51K | MUMBAI AIR (SAHAR) | ATLANTA, HARTSFIELD | AIR |
| SUPPLIER #9 — AJANTA PHARMA LTD · 7 shipments · $71K | |||||||||||
| 96 | Oct 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Capsule | 7.9K | NOS | $1.62 | $13K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 97 | Oct 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Capsule | 7.7K | NOS | $0.445 | $3K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 98 | Oct 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Capsule | 9.6K | NOS | $0.734 | $7K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 99 | Oct 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Capsule | 7.7K | NOS | $1.61 | $12K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 100 | Nov 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Capsule | 19.4K | NOS | $0.715 | $14K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 101 | Dec 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Capsule | 15.1K | NOS | $0.450 | $7K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 102 | Dec 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Capsule | 18.9K | NOS | $0.766 | $14K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| SUPPLIER #10 — TORRENT PHARMACEUTICALS LTD · 2 shipments · $14K | |||||||||||
| 103 | Oct 2025 | TORRENT DO BRASIL LTDAROD FERNAO DI | Brazil | Tablet | 4.7K | NOS | $2.90 | $14K | NHAVA SHEVA SEA (JNPT) | Santos | SEA |
| 104 | Dec 2025 | TORRENT DO BRASIL LTDA | Brazil | Tablet | 4.6K | NOS | $0.034 | $156.25 | NHAVA SHEVA SEA (JNPT) | Santos | SEA |
| SUPPLIER #11 — THE MADRAS PHARMACEUTICALS · 1 shipments · $10K | |||||||||||
| 105 | Dec 2025 | BONAPHARM S.A | Peru | Capsule | 9.2K | PCS | $1.07 | $10K | CHENNAI SEA | Callao | SEA |
| SUPPLIER #12 — XL LABORATORIES PVT LTD · 1 shipments · $10K | |||||||||||
| 106 | Nov 2025 | CAFERMA S.A | Peru | Capsule | 15.0K | NOS | $0.632 | $10K | TUGHLAKABAD ICD | Callao | ICD |
| SUPPLIER #13 — WESTCOAST PHARMACEUTICAL WORKS LTD · 2 shipments · $7K | |||||||||||
| 107 | Nov 2025 | UNLISTED BUYER | Dominican Republic | Capsule | 2.9K | NOS | $0.809 | $2K | AHMEDABAD ICD | CAUCEDO DOMINIC REP. | ICD |
| 108 | Nov 2025 | UNLISTED BUYER | Dominican Republic | Capsule | 21.0K | NOS | $0.210 | $4K | AHMEDABAD ICD | CAUCEDO DOMINIC REP. | ICD |
| SUPPLIER #14 — PEAK HEALTHCARE · 3 shipments · $696.53 | |||||||||||
| 109 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 150 | NOS | $2.32 | $348.37 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 110 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 150 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 111 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 150 | NOS | $2.32 | $348.16 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #15 — NARAYANA HRUDAYALAYA LTD · 3 shipments · $277.58 | |||||||||||
| 112 | Nov 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Tablet | 230 | NOS | $0.599 | $137.76 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| 113 | Nov 2025 | UNKNOWN BUYER | Cayman Islands | Tablet | 230 | NOS | $0.599 | $137.76 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| 114 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Tablet | 300 | NOS | $0.0068 | $2.05 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #16 — KALINDI OVERSEAS · 2 shipments · $27.96 | |||||||||||
| 115 | Nov 2025 | THE PHARMACIST | Cayman Islands | Tablet | 5 | NOS | $2.19 | $10.93 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| 116 | Dec 2025 | THE PHARMACIST | Cayman Islands | Tablet | 5 | NOS | $3.41 | $17.03 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
2 countries · 11 shipments · $608K · 3 Indian suppliers · 3 buyers
SHIPMENTS
11
USD
$608K
COUNTRIES
2
SUPPLIERS
3
BUYERS
3
HHI
5,064
concentrated
Top 2 destination countries in Oceania
1
Australia (100.0%)
$607K
2
Papua New Guinea (0.0%)
$130.36
Top 3 Indian suppliers into Oceania
1
CIPLA LTD
$339K
2
HETERO LABS LTD
$269K
3
BIOLOG PHARMA PVT LTD
$130.36
Top 2 Oceania importers
1
ARROW PHARMACEUTICALS PTY LTD · Australia
$339K
2
SADDOZ PTY LTD · Australia
$269K
Top 1 dosage forms
1
Tablet
$608K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $269K | $67K |
| Nov | 1 | $130.36 | $130.36 |
| Dec | 6 | $339K | $56K |
Shipment register · 11 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CIPLA LTD · 6 shipments · $339K | |||||||||||
| 1 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 583.2K | NOS | $0.092 | $54K | MUMBAI AIR (SAHAR) | SYDNEY | AIR |
| 2 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 567.0K | NOS | $0.099 | $56K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| 3 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 575.1K | NOS | $0.099 | $57K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| 4 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 583.2K | NOS | $0.099 | $58K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| 5 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 579.2K | NOS | $0.099 | $57K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| 6 | Dec 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 582.2K | NOS | $0.099 | $58K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| SUPPLIER #2 — HETERO LABS LTD · 4 shipments · $269K | |||||||||||
| 7 | Oct 2025 | SADDOZ PTY LTD | Australia | Tablet | 744.1K | NOS | $0.116 | $86K | HYDERABAD ICD | SYDNEY | ICD |
| 8 | Oct 2025 | SADDOZ PTY LTD | Australia | Tablet | 374.4K | NOS | $0.116 | $43K | HYDERABAD ICD | SYDNEY | ICD |
| 9 | Oct 2025 | SADDOZ PTY LTD | Australia | Tablet | 781.6K | NOS | $0.116 | $91K | HYDERABAD ICD | SYDNEY | ICD |
| 10 | Oct 2025 | SADDOZ PTY LTD | Australia | Tablet | 416.5K | NOS | $0.116 | $48K | HYDERABAD ICD | SYDNEY | ICD |
| SUPPLIER #3 — BIOLOG PHARMA PVT LTD · 1 shipments · $130.36 | |||||||||||
| 11 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 900 | NOS | $0.145 | $130.36 | AHMEDABAD AIR | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 46 Indian fenofibrate exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped fenofibrate in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | ABBOTT HEALTHCARE PVT LTD | SOLAN | 11 | $2.04M | Tablet | Europe |
| 2 | CIPLA LTD | PAREL MUMBAI MAHARASHTRA | 36 | $977K | Tablet, Capsule | Americas, Oceania |
| 3 | HETERO LABS LTD | HYDERABAD | 29 | $859K | Tablet | Oceania, Americas |
| 4 | ATHENA DRUG DELIVERY SOLUTIONS PVT LTD | ANDHERI EAST | 7 | $633K | Capsule, Pellets, Tablet | Europe, Asia |
| 5 | AMNEAL PHARMACEUTICALS PVT LTD | RAJODA | 6 | $329K | Tablet | Americas |
| 6 | TORRENT PHARMACEUTICALS LTD | AHMEDABAD. GUJARAT | 15 | $257K | Tablet, film-coated tablet | Americas, Europe |
| 7 | MANKIND PHARMA LTD | HIMANCHAL PRADESH | 16 | $226K | Tablet | Americas |
| 8 | ALEMBIC PHARMACEUTICALS LTD | GUJARAT | 14 | $220K | Capsule | Americas |
| 9 | INVENTIA HEALTHCARE LTD | MUMBAI | 5 | $150K | Capsule | Americas |
| 10 | COHANCE LIFESCIENCES LTD | Hyderabad | 1 | $137K | Other | Americas |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 5 | $125K | Capsule, Tablet | Europe |
| 12 | MYLAN LABORATORIES LTD | NASHIK | 2 | $105K | Tablet | Americas |
| 13 | AJANTA PHARMA LTD | MUMBAI. | 7 | $71K | Capsule | Americas |
| 14 | SASHA LIFE HEALTHCARE | MUMBAI | 3 | $43K | Capsule | Asia |
| 15 | MICRO LABS LTD | PONDICHERRY | 2 | $29K | Capsule | Asia |
| 16 | ZYDUS LIFESCIENCES LTD | AHMEDABAD/GUJRAT | 4 | $28K | Capsule | Asia |
| 17 | XL LABORATORIES PVT LTD | BHIWADI | 2 | $22K | Capsule | Americas, Asia |
| 18 | SCOTT EDIL PHARMACIA LTD | BADDI | 1 | $16K | Tablet | Asia |
| 19 | BHARAT PARENTERALS LTD | DIST.VADODARA | 1 | $13K | Tablet | Africa |
| 20 | THE MADRAS PHARMACEUTICALS | CHENNAI | 1 | $10K | Capsule | Americas |
| 21 | SAGA LIFESCIENCES LTD | TALUKA SANAND | 1 | $8K | Tablet | Asia |
| 22 | WESTCOAST PHARMACEUTICAL WORKS LTD | AHMEDABAD | 2 | $7K | Capsule | Americas |
| 23 | TRIOPLUS PHARMACEUTICALS PVT LTD | MINDSPACE | 1 | $7K | Tablet | Africa |
| 24 | TROIKAA PHARMACEUTICALS LTD | DEHRADUN | 1 | $6K | Tablet | Asia |
| 25 | HIGHKON PHARMA | NEW DELHI | 3 | $6K | Tablet | Asia |
| 26 | MACLEODS PHARMACEUTICALS LTD | BHIWANDI | 2 | $4K | Tablet | Asia |
| 27 | PHARMA ALACRITY LLP | Kolkata | 1 | $2K | Tablet | Asia |
| 28 | DERRIC WOOD | SUBHASH PLACE | 26 | $829.07 | Tablet, Capsule | Asia |
| 29 | PEAK HEALTHCARE | MUMBAI | 3 | $696.53 | Tablet | Americas |
| 30 | BAKER & DAVIS PVT LTD | MUMBAI | 4 | $629.05 | Tablet | Africa |
| 31 | SAVA HEALTHCARE LTD | PUNE | 5 | $362.23 | Tablet | Africa |
| 32 | NARAYANA HRUDAYALAYA LTD | BANGALORE | 3 | $277.58 | Tablet | Americas |
| 33 | MATOSHREE HEALTH CARE PVT LTD | THAKURDWAR MUMBAI | 1 | $201.94 | Tablet | Africa |
| 34 | MDS ENTERPRISES | MUMBAI | 1 | $158.77 | Tablet | Africa |
| 35 | BIOLOG PHARMA PVT LTD | AHMEDABAD | 1 | $130.36 | Tablet | Oceania |
| 36 | KLV HEALTHCARE PVT LTD | DAHISAR | 1 | $120.00 | Tablet | Africa |
| 37 | HANSI TRADERS | HOSPITAL ROAD | 1 | $95.84 | Capsule | Africa |
| 38 | FALCON TRANSGLOBAL | NAGPUR | 3 | $64.42 | Tablet | Asia |
| 39 | LAWRENCE WALTER | DELHI | 3 | $47.22 | Tablet | Asia |
| 40 | RAVIAN LIFE SCIENCE PVT LTD | HARIDWAR | 2 | $38.82 | Tablet | Asia |
| 41 | KALINDI OVERSEAS | MUMBAI | 2 | $27.96 | Tablet | Americas |
| 42 | MEDICOS LIFESCIENCES | AHMEDABAD | 1 | $20.10 | Tablet | Africa |
| 43 | BABA AGENCIES | Chennai | 1 | $18.36 | Tablet | Asia |
| 44 | AL-SUPREME EXPORTS | NAGERCOIL | 1 | $4.17 | Tablet | Africa |
| 45 | CURE EARTH PHARMA | Chennai | 1 | $1.92 | Tablet | Africa |
| 46 | DEN MARK PHARMACEUTICALS PVT LTD | HARIDWAR | 2 | $0.458 | Tablet | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 49 global fenofibrate importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian fenofibrate in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MYLAN HUNGARY KFT | Hungary | 9 | $2.03M | ABBOTT HEALTHCARE PV… | Tablet |
| 2 | HANLIM PHARM. CO LTD | South Korea | 1 | $548K | ATHENA DRUG DELIVERY… | Pellets |
| 3 | CIPLA USA INC | United States | 19 | $359K | CIPLA LTD | Tablet |
| 4 | ARROW PHARMACEUTICALS PTY LTD | Australia | 6 | $339K | CIPLA LTD | Tablet |
| 5 | AMNEAL PHARMACEUTICALS LLC | United States | 6 | $329K | AMNEAL PHARMACEUTICA… | Tablet |
| 6 | SADDOZ PTY LTD | Australia | 4 | $269K | HETERO LABS LTD | Tablet |
| 7 | J. KNIPPER & COMPANY | United States | 11 | $163K | ALEMBIC PHARMACEUTIC… | Capsule |
| 8 | COMEXPORT TRADING COMERCIO EXTERIOR | Brazil | 1 | $137K | COHANCE LIFESCIENCES… | Other |
| 9 | YUSEN LOGISTICS BENELUX BELGIUM | Belgium | 5 | $125K | SUN PHARMACEUTICAL I… | Capsule, Tablet |
| 10 | NORTHSTAR DISTRIBUTION CENTER | United States | 8 | $117K | MANKIND PHARMA LTD | Tablet |
| 11 | HEUMANN PHARMA GMBH | Malta | 8 | $110K | TORRENT PHARMACEUTIC… | Tablet, film-coated tablet |
| 12 | LIFESTAR PHARMA LLC | United States | 8 | $109K | MANKIND PHARMA LTD | Tablet |
| 13 | MYLAN PHARMACEUTICALS INC | United States | 2 | $105K | MYLAN LABORATORIES LTD | Tablet |
| 14 | TORRENT PHARMA (UK) LTD | United Kingdom | 3 | $95K | TORRENT PHARMACEUTIC… | Tablet |
| 15 | ANIP ACQUISITION COMPANY | United States | 3 | $86K | INVENTIA HEALTHCARE … | Capsule |
| 16 | AGENCIAS CELMAR | Panama | 2 | $75K | CIPLA LTD | Capsule |
| 17 | MCKESSON THIRD PARTY LOGISTICS | United States | 7 | $71K | AJANTA PHARMA LTD | Capsule |
| 18 | APL SWIFT SERVICES (MALTA) LTD | Malta | 3 | $44K | ATHENA DRUG DELIVERY… | Capsule |
| 19 | 4LIFE HEALTHCARE INC | Philippines | 3 | $43K | SASHA LIFE HEALTHCARE | Capsule |
| 20 | ADK PHARMACEUTICAL COMPANY PVT LTD | Maldives | 2 | $29K | MICRO LABS LTD | Capsule |
| 21 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | 4 | $28K | ZYDUS LIFESCIENCES LTD | Capsule |
| 22 | OMAN PHARMACEUTICAL PRODUCTS CO LLC | Oman | 1 | $26K | HETERO LABS LTD | Tablet |
| 23 | 2CARE4 GENERICS APS | Denmark | 1 | $22K | ATHENA DRUG DELIVERY… | Capsule |
| 24 | CAMBER PHARMACEUTICALS INC | United States | 1 | $21K | HETERO LABS LTD | Tablet |
| 25 | TECNIMEDE-SOCIEDADE TCNICO-MEDICIN | Portugal | 1 | $19K | ATHENA DRUG DELIVERY… | Capsule |
| 26 | TORRENT DO BRASIL LTDAROD FERNAO DI | Brazil | 1 | $14K | TORRENT PHARMACEUTIC… | Tablet |
| 27 | M/S.CHANRAIHEALTH CARE LTD | Nigeria | 1 | $13K | BHARAT PARENTERALS LTD | Tablet |
| 28 | AMBICA INTERNATIONAL CORP | Philippines | 1 | $12K | XL LABORATORIES PVT … | Capsule |
| 29 | BONAPHARM S.A | Peru | 1 | $10K | THE MADRAS PHARMACEU… | Capsule |
| 30 | CAFERMA S.A | Peru | 1 | $10K | XL LABORATORIES PVT … | Capsule |
| 31 | MSJ PHARMACEUTICALS | Sierra Leone | 1 | $7K | TRIOPLUS PHARMACEUTI… | Tablet |
| 32 | A.P.C. (P) L | Maldives | 1 | $6K | TROIKAA PHARMACEUTIC… | Tablet |
| 33 | DKSH MALAYSIA SDN BHD | Malaysia | 2 | $4K | MACLEODS PHARMACEUTI… | Tablet |
| 34 | ALEMBIC PHARMACEUTICALS SPA | Chile | 1 | $4K | ALEMBIC PHARMACEUTIC… | Capsule |
| 35 | STANLEY BIOTECH COMPANY LTD | Myanmar | 1 | $2K | PHARMA ALACRITY LLP | Tablet |
| 36 | EMIRATES POST COMPANY | United Arab Emirates | 25 | $771.78 | DERRIC WOOD | Tablet, Capsule |
| 37 | ASTREA FONTAINE SAS | France | 1 | $434.09 | ABBOTT HEALTHCARE PV… | Tablet |
| 38 | FREIGHTER MADE LOGISTICS LTD | Ghana | 3 | $429.40 | BAKER & DAVIS PVT LTD | Tablet |
| 39 | CRESCENT PHARMA LTD | United Kingdom | 1 | $405.12 | ATHENA DRUG DELIVERY… | Tablet |
| 40 | REGENCY EXIM TRADE LTD | Mauritius | 5 | $362.23 | SAVA HEALTHCARE LTD | Tablet |
| 41 | TORRENT DO BRASIL LTDA | Brazil | 1 | $156.25 | TORRENT PHARMACEUTIC… | Tablet |
| 42 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | 2 | $139.81 | NARAYANA HRUDAYALAYA… | Tablet |
| 43 | EMIRATES POST GROUP | United Arab Emirates | 3 | $64.42 | FALCON TRANSGLOBAL | Tablet |
| 44 | PHARMAKON BIOTEC INC | Philippines | 2 | $38.82 | RAVIAN LIFE SCIENCE … | Tablet |
| 45 | THE PHARMACIST | Cayman Islands | 2 | $27.96 | KALINDI OVERSEAS | Tablet |
| 46 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | 1 | $20.10 | MEDICOS LIFESCIENCES | Tablet |
| 47 | VITAL RANK SDN BHD | Malaysia | 1 | $18.36 | BABA AGENCIES | Tablet |
| 48 | GOOD HEALTH (PTY) LTD | Seychelles | 1 | $4.17 | AL-SUPREME EXPORTS | Tablet |
| 49 | KALKAAL HOSPITAL | Somalia | 1 | $1.92 | CURE EARTH PHARMA | Tablet |
This report covers 241 2025-Q4 Fenofibrate shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/fenofibrate
Talk to our trade analyst
Need a custom fenofibrate report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/fenofibrate
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Fenofibrate product page
Live data, supplier directory, price trends, and trade route analysis